210 related articles for article (PubMed ID: 15158448)
1. Sall1, a causative gene for Townes-Brocks syndrome, enhances the canonical Wnt signaling by localizing to heterochromatin.
Sato A; Kishida S; Tanaka T; Kikuchi A; Kodama T; Asashima M; Nishinakamura R
Biochem Biophys Res Commun; 2004 Jun; 319(1):103-13. PubMed ID: 15158448
[TBL] [Abstract][Full Text] [Related]
2. Mouse homolog of SALL1, a causative gene for Townes-Brocks syndrome, binds to A/T-rich sequences in pericentric heterochromatin via its C-terminal zinc finger domains.
Yamashita K; Sato A; Asashima M; Wang PC; Nishinakamura R
Genes Cells; 2007 Feb; 12(2):171-82. PubMed ID: 17295837
[TBL] [Abstract][Full Text] [Related]
3. Mammary gland development requires syndecan-1 to create a beta-catenin/TCF-responsive mammary epithelial subpopulation.
Liu BY; Kim YC; Leatherberry V; Cowin P; Alexander CM
Oncogene; 2003 Dec; 22(58):9243-53. PubMed ID: 14681683
[TBL] [Abstract][Full Text] [Related]
4. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation.
Esufali S; Bapat B
Oncogene; 2004 Oct; 23(50):8260-71. PubMed ID: 15377999
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the SALL1 putative transcription factor gene cause Townes-Brocks syndrome.
Kohlhase J; Wischermann A; Reichenbach H; Froster U; Engel W
Nat Genet; 1998 Jan; 18(1):81-3. PubMed ID: 9425907
[TBL] [Abstract][Full Text] [Related]
6. Expression of a truncated Sall1 transcriptional repressor is responsible for Townes-Brocks syndrome birth defects.
Kiefer SM; Ohlemiller KK; Yang J; McDill BW; Kohlhase J; Rauchman M
Hum Mol Genet; 2003 Sep; 12(17):2221-7. PubMed ID: 12915476
[TBL] [Abstract][Full Text] [Related]
7. EBP50, a beta-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma.
Shibata T; Chuma M; Kokubu A; Sakamoto M; Hirohashi S
Hepatology; 2003 Jul; 38(1):178-86. PubMed ID: 12830000
[TBL] [Abstract][Full Text] [Related]
8. Defining the heterochromatin localization and repression domains of SALL1.
Netzer C; Bohlander SK; Hinzke M; Chen Y; Kohlhase J
Biochim Biophys Acta; 2006 Mar; 1762(3):386-91. PubMed ID: 16443351
[TBL] [Abstract][Full Text] [Related]
9. Murine Nr4a1 and Herpud1 are up-regulated by Wnt-1, but the homologous human genes are independent from beta-catenin activation.
Chtarbova S; Nimmrich I; Erdmann S; Herter P; Renner M; Kitajewski J; Müller O
Biochem J; 2002 Nov; 367(Pt 3):723-8. PubMed ID: 12153396
[TBL] [Abstract][Full Text] [Related]
10. SALL1 mutation analysis in Townes-Brocks syndrome: twelve novel mutations and expansion of the phenotype.
Botzenhart EM; Green A; Ilyina H; König R; Lowry RB; Lo IF; Shohat M; Burke L; McGaughran J; Chafai R; Pierquin G; Michaelis RC; Whiteford ML; Simola KO; Rösler B; Kohlhase J
Hum Mutat; 2005 Sep; 26(3):282. PubMed ID: 16088922
[TBL] [Abstract][Full Text] [Related]
11. Menin promotes the Wnt signaling pathway in pancreatic endocrine cells.
Chen G; A J; Wang M; Farley S; Lee LY; Lee LC; Sawicki MP
Mol Cancer Res; 2008 Dec; 6(12):1894-907. PubMed ID: 19074834
[TBL] [Abstract][Full Text] [Related]
12. A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex.
Hämmerlein A; Weiske J; Huber O
Cell Mol Life Sci; 2005 Mar; 62(5):606-18. PubMed ID: 15747065
[TBL] [Abstract][Full Text] [Related]
13. Beta-catenin is critical for dendritic morphogenesis.
Yu X; Malenka RC
Nat Neurosci; 2003 Nov; 6(11):1169-77. PubMed ID: 14528308
[TBL] [Abstract][Full Text] [Related]
14. SALL1 mutations in Townes-Brocks syndrome and related disorders.
Kohlhase J
Hum Mutat; 2000 Dec; 16(6):460-6. PubMed ID: 11102974
[TBL] [Abstract][Full Text] [Related]
15. HIC1 attenuates Wnt signaling by recruitment of TCF-4 and beta-catenin to the nuclear bodies.
Valenta T; Lukas J; Doubravska L; Fafilek B; Korinek V
EMBO J; 2006 Jun; 25(11):2326-37. PubMed ID: 16724116
[TBL] [Abstract][Full Text] [Related]
16. SALL1, the gene mutated in Townes-Brocks syndrome, encodes a transcriptional repressor which interacts with TRF1/PIN2 and localizes to pericentromeric heterochromatin.
Netzer C; Rieger L; Brero A; Zhang CD; Hinzke M; Kohlhase J; Bohlander SK
Hum Mol Genet; 2001 Dec; 10(26):3017-24. PubMed ID: 11751684
[TBL] [Abstract][Full Text] [Related]
17. Wnt signaling through canonical and non-canonical pathways: recent progress.
Widelitz R
Growth Factors; 2005 Jun; 23(2):111-6. PubMed ID: 16019432
[TBL] [Abstract][Full Text] [Related]
18. Detection of heterozygous SALL1 deletions by quantitative real time PCR proves the contribution of a SALL1 dosage effect in the pathogenesis of Townes-Brocks syndrome.
Borozdin W; Steinmann K; Albrecht B; Bottani A; Devriendt K; Leipoldt M; Kohlhase J
Hum Mutat; 2006 Feb; 27(2):211-2. PubMed ID: 16429401
[TBL] [Abstract][Full Text] [Related]
19. Cell biology. Wnt signaling glows with RNAi.
Fearon ER; Cadigan KM
Science; 2005 May; 308(5723):801-3. PubMed ID: 15879199
[No Abstract] [Full Text] [Related]
20. The murine homolog of SALL4, a causative gene in Okihiro syndrome, is essential for embryonic stem cell proliferation, and cooperates with Sall1 in anorectal, heart, brain and kidney development.
Sakaki-Yumoto M; Kobayashi C; Sato A; Fujimura S; Matsumoto Y; Takasato M; Kodama T; Aburatani H; Asashima M; Yoshida N; Nishinakamura R
Development; 2006 Aug; 133(15):3005-13. PubMed ID: 16790473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]